DermoSafe

DermoSafe SA, a Swiss medtech company established in November 2012, is positioned to address the critical need for early melanoma detection. The company was founded by Philippe Held, who currently serves as CEO and holds an engineering degree in electrotechnics and a postgrade in management. His venture into digital health was spurred by winning the AXA Innovation Award, which provided the initial impetus to set up the company. The founding team was rounded out by co-founder and co-investor Dr. Eugen Grecu, who brought executive experience from major pharmaceutical groups.

DermoSafe operates in the teledermatology market, offering a comprehensive service that connects patients, primary care practitioners, and specialist dermatologists through a digital platform. The business model is centered on providing a complete, integrated solution for skin cancer screening, rather than just selling a device. The company's core offering is a service that facilitates rapid and precise access to melanoma diagnosis through the integration of a medical device, a web platform, and a virtual competence center. This approach aims to democratize the use of dermoscopy, a technique traditionally limited to specialists.

The company's product ecosystem consists of the DermoClic device and the DermoConnect platform. DermoClic is a user-friendly device designed for capturing high-definition dermoscopic images of skin lesions, ensuring consistent quality regardless of the operator's skill level. These images are then transferred to the secure and medically certified DermoConnect web platform. This platform serves two primary functions: creating patient records and enabling remote diagnosis by expert dermatologists. Following the specialist's analysis, the platform generates a customized report. This integrated system is designed to streamline the diagnostic process, allowing general practitioners or even pharmacists to offer initial screenings, with suspicious cases being efficiently escalated to dermatologists who already have the necessary images and information for their assessment.

Keywords: teledermatology, melanoma detection, skin cancer screening, medical device, digital health, dermoscopy, e-health, remote diagnosis, medtech, DermoClic, DermoConnect, Philippe Held, virtual consultation, medical imaging, healthcare technology, diagnostic platform, early detection, dermatology, Swiss startup, AXA Innovation Award